Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Could there be a possible ban on Disposable Wet Wipes?

Jun 8, 2018

As evident in the recent ban of plastic microbeads in many countries, there are a lot of efforts to reduce the number of single-use plastic products that go to waste. For example, disposable wet wipes. The popular household item can be sold for many uses, including...

Where will Medical Cannabis go After Recreational Cannabis Legalization?

Jun 6, 2018

The impending legalization of cannabis for recreational use in Canada is creating a lot of discussion in several circles. This was a major topic at the medical conference for the Canadian Consortium for the Investigation of Cannabinoids where many researchers,...

Consultation Summary of the Regulation of Vaping Products in Canada

May 30, 2018

Back in 2016, the Government of Canada introduced Bill S-5. This bill was intended to amend the Tobacco Act and rename it the Tobacco and Vaping Products Act (TVPA). TVPA proposes to regulate the manufacture, sale, labelling and promotion of vaping products separate...

Health Canada To Put Much Needed Warnings On Opioid Medications

May 25, 2018

Opioids medications are known to effectively relieve many patients of pain. They include drugs such as oxycodone, morphine, fentanyl and codeine, and are available through prescription administration only and vary in strength of pain relief. However, the use of...

Are CBD-Containing Cosmetics the Next New Trend?

May 23, 2018

As public perception of cannabis continues to change, and the public becomes more conscious of the source of their personal care ingredients, many are looking to the cannabis plant. Cannabis has a multitude of medical benefits, including relieving inflammation, pain,...

Hawaii to ban environment-disrupting sunscreen ingredients

May 18, 2018

Hawaii is largely known by its beaches and coral reefs. However, with recent changes to the climate and also human impact threatening to destroy its marine environment and surrounding ecosystems, the state is working to prevent further environmental damage. This...

Sustainable Water Use in the Cosmetics Industry

May 16, 2018

As more and more consumers are becoming aware of the environmental impact of their day to day lives, many are looking to change the way they consume and use certain resources – water being one of them. More individuals are viewing water as a limited resource and one...

First Artificial Intelligence Based Medical Device Permitted for Use by the FDA

May 11, 2018

With the ever-increasing development of artificial intelligence, there’s no surprise that the medical industry is catching up. In April of this year, the FDA has permitted the marketing and use of a medical device that uses artificial intelligence to detect diabetic...

FDA Guidelines on the Inclusion of Pregnant Women in Clinical Trials

May 9, 2018

Earlier this month, the US FDA published a draft guidance for the inclusion of pregnant women in drug and therapeutic product development clinical trials as well as safety measures that should be taken in place to prevent potential fetal risk. The guidance discusses...

Why the Economy Needs the Pharmaceutical Industry

May 4, 2018

There are many qualities that need to be analyzed when determining the state of a country’s economy. For example, the strength of the many industries that help develop it as well as the amount of research and innovation present and how it is assisting in driving the...

« Older Entries

Next Entries »

“Focal Point Research has consistently and professionally looked after regulatory and quality issues of our brand for years. Through a courteous and knowledgeable team, they have managed to navigate us through an ever changing regulatory landscape while maintaining our interests, and allowed us to correctly distribute and sell within Canada.”

“I have truly enjoyed working with you over the last 8 years! You and your team have been an amazing resource for me. I have always been impressed by the knowledge and professionalism of everyone at Focal Point, which is a true testament to your leadership.”

Connect With Us

The Focal Point Research team is ready to help with all of your scientific and regulatory needs. Our team has the experience and expertise you need to see your product to market and we are eager to help you.

181 Lakeshore Road E. Mississauga, ON

1 (905) 271 2709

mail@focalpointresearch.net

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.

Connect With Us